Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Dipeptidyl Peptidase IV (DPP-IV), food grade
Cat No.
NATC-205
Description
Dipeptidyl polypeptidase IV (DPPIV), also known as adenosine deaminase complex protein 2 or CD26, is an antigenic enzyme expressed on the surface of most cell types and is associated with immunomodulation, signaling and apoptosis. It is an innate membrane glycoprotein and serine exopeptidase.DPPIV plays an important role in glucose metabolism and is responsible for the degradation of enteric insulin such as GLP-1. In addition, it inhibits the development of cancer and tumors. It plays a pathogenic role in the development of fibrosis in many organs such as the liver and kidney.DPPIV plays an important role in tumor biology and is a potent marker for a variety of cancers, with levels elevated on the cell surface of some tumors or in serum, and decreased in others. Middle East Respiratory Syndrome Coronavirus, a new SARS-related coronavirus, has been found to bind DPPIV. DPPIVs are found on the cell surface of airways (e.g., lungs) and kidneys, and scientists have used them to their advantage to block viral entry into cells.
Source
Aspergillus oryzae
Applications
Dipeptidyl polypeptidase IV (DPP-IV) is an important protein hydrolyzing enzyme with multiple applications:
Treatment of diabetes: DPP-IV inhibitors such as sitagliptin and riligliptin prolong the action of GLP-1 to help control blood glucose.
Immunomodulation: DPP-IV plays a role in T cell activation and inhibitors can be used to modulate autoimmune diseases.
Cancer research: DPP-IV is aberrantly expressed in certain cancers and is a potential therapeutic target.
Obesity and Metabolic Syndrome: By potentiating the effects of GLP-1, DPP-IV inhibitors can be used for weight management and metabolic health.
Neurological disorders: DPP-IV inhibitors have potential in Alzheimer's disease and Parkinson's disease to reduce neuroinflammation and protect neurons.
Treatment of diabetes: DPP-IV inhibitors such as sitagliptin and riligliptin prolong the action of GLP-1 to help control blood glucose.
Immunomodulation: DPP-IV plays a role in T cell activation and inhibitors can be used to modulate autoimmune diseases.
Cancer research: DPP-IV is aberrantly expressed in certain cancers and is a potential therapeutic target.
Obesity and Metabolic Syndrome: By potentiating the effects of GLP-1, DPP-IV inhibitors can be used for weight management and metabolic health.
Neurological disorders: DPP-IV inhibitors have potential in Alzheimer's disease and Parkinson's disease to reduce neuroinflammation and protect neurons.
Appearance
Light-yellow Powder
Form
Powder
Storage
Store in a cool, ventilated and dry place, avoid direct sunlight.
Specific Activity
20000 DPP IV-PANU/g
Download
Download Datasheet